

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tryptophan catabolic process (GO:0006569) | 5.22147618 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.22147618 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.22147618 |
| 4 | indolalkylamine metabolic process (GO:0006586) | 4.94846344 |
| 5 | kynurenine metabolic process (GO:0070189) | 4.66633700 |
| 6 | tryptophan metabolic process (GO:0006568) | 4.62121452 |
| 7 | cellular response to ethanol (GO:0071361) | 4.59595154 |
| 8 | signal peptide processing (GO:0006465) | 4.44795693 |
| 9 | regulation of pigment cell differentiation (GO:0050932) | 4.27130329 |
| 10 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.15165513 |
| 11 | positive regulation of developmental pigmentation (GO:0048087) | 4.10753773 |
| 12 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.00036237 |
| 13 | interkinetic nuclear migration (GO:0022027) | 3.94742666 |
| 14 | regulation of sarcomere organization (GO:0060297) | 3.75955297 |
| 15 | protein K48-linked deubiquitination (GO:0071108) | 3.70132033 |
| 16 | detection of light stimulus involved in visual perception (GO:0050908) | 3.62170503 |
| 17 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.62170503 |
| 18 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.51434105 |
| 19 | photoreceptor cell maintenance (GO:0045494) | 3.51189562 |
| 20 | protein K11-linked deubiquitination (GO:0035871) | 3.42509841 |
| 21 | establishment of protein localization to Golgi (GO:0072600) | 3.39730554 |
| 22 | indole-containing compound metabolic process (GO:0042430) | 3.39565272 |
| 23 | NAD biosynthetic process (GO:0009435) | 3.32677065 |
| 24 | benzene-containing compound metabolic process (GO:0042537) | 3.30268232 |
| 25 | cellular biogenic amine catabolic process (GO:0042402) | 3.17580871 |
| 26 | amine catabolic process (GO:0009310) | 3.17580871 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 3.15792089 |
| 28 | regulation of hippo signaling (GO:0035330) | 3.07730240 |
| 29 | protein K63-linked deubiquitination (GO:0070536) | 3.04198402 |
| 30 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.01587856 |
| 31 | neural tube formation (GO:0001841) | 2.99699726 |
| 32 | tachykinin receptor signaling pathway (GO:0007217) | 2.97394579 |
| 33 | phospholipid translocation (GO:0045332) | 2.92982805 |
| 34 | lipid translocation (GO:0034204) | 2.92982805 |
| 35 | negative regulation of complement activation (GO:0045916) | 2.91103642 |
| 36 | prenylation (GO:0097354) | 2.90727937 |
| 37 | protein prenylation (GO:0018342) | 2.90727937 |
| 38 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.90575196 |
| 39 | auditory receptor cell stereocilium organization (GO:0060088) | 2.88041235 |
| 40 | L-fucose catabolic process (GO:0042355) | 2.87476919 |
| 41 | fucose catabolic process (GO:0019317) | 2.87476919 |
| 42 | L-fucose metabolic process (GO:0042354) | 2.87476919 |
| 43 | ketone body metabolic process (GO:1902224) | 2.77391713 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 2.72210394 |
| 45 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.70063253 |
| 46 | snRNA transcription (GO:0009301) | 2.69194028 |
| 47 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.67302737 |
| 48 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.67302737 |
| 49 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.67302737 |
| 50 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.67183180 |
| 51 | regulation of establishment of cell polarity (GO:2000114) | 2.64851635 |
| 52 | axoneme assembly (GO:0035082) | 2.62896772 |
| 53 | one-carbon compound transport (GO:0019755) | 2.61930247 |
| 54 | thyroid hormone metabolic process (GO:0042403) | 2.60939270 |
| 55 | gamma-aminobutyric acid transport (GO:0015812) | 2.60170193 |
| 56 | reflex (GO:0060004) | 2.59570337 |
| 57 | behavioral response to nicotine (GO:0035095) | 2.51854446 |
| 58 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.51815333 |
| 59 | regulation of gene silencing by miRNA (GO:0060964) | 2.51815333 |
| 60 | regulation of gene silencing by RNA (GO:0060966) | 2.51815333 |
| 61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.51660971 |
| 62 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.51635043 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 2.51358980 |
| 64 | aromatic amino acid family metabolic process (GO:0009072) | 2.51021594 |
| 65 | flavonoid metabolic process (GO:0009812) | 2.50449704 |
| 66 | serotonin metabolic process (GO:0042428) | 2.50116078 |
| 67 | cellular response to sterol (GO:0036315) | 2.49284071 |
| 68 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.48022793 |
| 69 | sphingoid metabolic process (GO:0046519) | 2.47873654 |
| 70 | oxidative demethylation (GO:0070989) | 2.46937235 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46341644 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.46162135 |
| 73 | primary amino compound metabolic process (GO:1901160) | 2.45711567 |
| 74 | regulation of skeletal muscle contraction (GO:0014819) | 2.45559540 |
| 75 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.45029753 |
| 76 | negative regulation of mast cell activation (GO:0033004) | 2.44154029 |
| 77 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.44038091 |
| 78 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.43934343 |
| 79 | negative regulation of B cell mediated immunity (GO:0002713) | 2.43934343 |
| 80 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.40241998 |
| 81 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.40241998 |
| 82 | membrane depolarization during action potential (GO:0086010) | 2.39291612 |
| 83 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.36411243 |
| 84 | DNA demethylation (GO:0080111) | 2.36231582 |
| 85 | protein targeting to vacuole (GO:0006623) | 2.35761034 |
| 86 | protein targeting to lysosome (GO:0006622) | 2.35761034 |
| 87 | establishment of protein localization to vacuole (GO:0072666) | 2.35761034 |
| 88 | regulation of memory T cell differentiation (GO:0043380) | 2.35069994 |
| 89 | striated muscle atrophy (GO:0014891) | 2.34722127 |
| 90 | regulation of developmental pigmentation (GO:0048070) | 2.34563451 |
| 91 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.34133179 |
| 92 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.33890736 |
| 93 | sulfation (GO:0051923) | 2.33822555 |
| 94 | cytokine biosynthetic process (GO:0042089) | 2.33587279 |
| 95 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.32751085 |
| 96 | behavioral response to ethanol (GO:0048149) | 2.32376512 |
| 97 | positive regulation of phosphatase activity (GO:0010922) | 2.31137602 |
| 98 | histone H3-K4 trimethylation (GO:0080182) | 2.29630834 |
| 99 | negative regulation of humoral immune response (GO:0002921) | 2.29066971 |
| 100 | cAMP catabolic process (GO:0006198) | 2.28308046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15149188 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.67547695 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65877448 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.59353651 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51543576 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.42701972 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.39827813 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36362850 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28328200 |
| 10 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.13946212 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08890410 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07131031 |
| 13 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.06195098 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00605404 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92202177 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.91596153 |
| 17 | STAT3_23295773_ChIP-Seq_U87_Human | 1.88620525 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.87804748 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.86367335 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85912960 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.80710552 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79614890 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71011776 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67880546 |
| 25 | TCF4_23295773_ChIP-Seq_U87_Human | 1.65299829 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64348074 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60200247 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59739865 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59013024 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58930153 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58727258 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58330934 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.58025160 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57933021 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53675853 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53675853 |
| 37 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.53260741 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51210227 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48014672 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46790446 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43889244 |
| 42 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.43806286 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42833909 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42604656 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.42604656 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42294045 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42017037 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41099728 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40825677 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40416575 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39070725 |
| 52 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35662338 |
| 53 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35194233 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34655584 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34534820 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32326720 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.31452303 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31013226 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30186899 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29126325 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26947857 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26592588 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25896269 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25797558 |
| 65 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25526740 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25166269 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25147256 |
| 68 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22728219 |
| 69 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22618932 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22482489 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21718645 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21391672 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19399266 |
| 74 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18732586 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17409448 |
| 76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17339587 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17108885 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16007583 |
| 79 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15952343 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15013484 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14455085 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12477885 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11939439 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11939439 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10791895 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10791895 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09757073 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08415785 |
| 89 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07792381 |
| 90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.07320387 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06914063 |
| 92 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06326618 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05992802 |
| 94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04268536 |
| 95 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03937173 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03083189 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02989685 |
| 98 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02913736 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02808940 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01494177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.97978269 |
| 2 | MP0003195_calcinosis | 3.50948164 |
| 3 | MP0008057_abnormal_DNA_replication | 3.37207730 |
| 4 | MP0001501_abnormal_sleep_pattern | 2.87456791 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.53652068 |
| 6 | MP0003045_fibrosis | 2.42115947 |
| 7 | MP0003646_muscle_fatigue | 2.40886643 |
| 8 | MP0005551_abnormal_eye_electrophysiolog | 2.26225869 |
| 9 | MP0004043_abnormal_pH_regulation | 2.22055099 |
| 10 | MP0004147_increased_porphyrin_level | 2.11460310 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.01094450 |
| 12 | MP0009046_muscle_twitch | 2.00028802 |
| 13 | MP0002102_abnormal_ear_morphology | 1.89503125 |
| 14 | MP0010386_abnormal_urinary_bladder | 1.87650422 |
| 15 | MP0001968_abnormal_touch/_nociception | 1.84263730 |
| 16 | MP0005310_abnormal_salivary_gland | 1.79477774 |
| 17 | MP0001986_abnormal_taste_sensitivity | 1.78234788 |
| 18 | MP0005646_abnormal_pituitary_gland | 1.77040356 |
| 19 | MP0005670_abnormal_white_adipose | 1.73194992 |
| 20 | MP0005253_abnormal_eye_physiology | 1.71794583 |
| 21 | MP0005671_abnormal_response_to | 1.71192143 |
| 22 | MP0000383_abnormal_hair_follicle | 1.70941924 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.69225618 |
| 24 | MP0008872_abnormal_physiological_respon | 1.61606348 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.60490689 |
| 26 | MP0002736_abnormal_nociception_after | 1.60064929 |
| 27 | MP0003252_abnormal_bile_duct | 1.58612433 |
| 28 | MP0000427_abnormal_hair_cycle | 1.57302666 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.47934515 |
| 30 | MP0003724_increased_susceptibility_to | 1.46751592 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.46115098 |
| 32 | MP0002168_other_aberrant_phenotype | 1.38204256 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.36585667 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.35794576 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.34887554 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.33752840 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.24157696 |
| 38 | MP0009745_abnormal_behavioral_response | 1.22536281 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.21004392 |
| 40 | MP0004142_abnormal_muscle_tone | 1.20631925 |
| 41 | MP0001800_abnormal_humoral_immune | 1.18954416 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.18179701 |
| 43 | MP0006082_CNS_inflammation | 1.16386899 |
| 44 | MP0004130_abnormal_muscle_cell | 1.14549008 |
| 45 | MP0000230_abnormal_systemic_arterial | 1.13728499 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.13446594 |
| 47 | MP0006054_spinal_hemorrhage | 1.13439169 |
| 48 | MP0009764_decreased_sensitivity_to | 1.07215786 |
| 49 | MP0002928_abnormal_bile_duct | 1.06614157 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.05704551 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.04162922 |
| 52 | MP0000371_diluted_coat_color | 1.03783410 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.03686604 |
| 54 | MP0001486_abnormal_startle_reflex | 1.02016093 |
| 55 | MP0004215_abnormal_myocardial_fiber | 0.99785345 |
| 56 | MP0002229_neurodegeneration | 0.99421201 |
| 57 | MP0005266_abnormal_metabolism | 0.99212325 |
| 58 | MP0003633_abnormal_nervous_system | 0.98887460 |
| 59 | MP0000372_irregular_coat_pigmentation | 0.98596107 |
| 60 | MP0003787_abnormal_imprinting | 0.97423855 |
| 61 | MP0002693_abnormal_pancreas_physiology | 0.97406867 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 0.96623674 |
| 63 | MP0005647_abnormal_sex_gland | 0.93802699 |
| 64 | MP0009115_abnormal_fat_cell | 0.93405190 |
| 65 | MP0005083_abnormal_biliary_tract | 0.92967863 |
| 66 | MP0004924_abnormal_behavior | 0.92673024 |
| 67 | MP0005386_behavior/neurological_phenoty | 0.92673024 |
| 68 | MP0004084_abnormal_cardiac_muscle | 0.91736263 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.91629850 |
| 70 | MP0001790_abnormal_immune_system | 0.90930624 |
| 71 | MP0005387_immune_system_phenotype | 0.90930624 |
| 72 | MP0005395_other_phenotype | 0.90557934 |
| 73 | MP0001756_abnormal_urination | 0.89739324 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.89280850 |
| 75 | MP0001545_abnormal_hematopoietic_system | 0.88659654 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 0.88659654 |
| 77 | MP0000538_abnormal_urinary_bladder | 0.88204856 |
| 78 | MP0002272_abnormal_nervous_system | 0.87054356 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 0.86563996 |
| 80 | MP0001970_abnormal_pain_threshold | 0.86424913 |
| 81 | MP0002723_abnormal_immune_serum | 0.86025713 |
| 82 | MP0010678_abnormal_skin_adnexa | 0.85154918 |
| 83 | MP0002064_seizures | 0.82399894 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.82265907 |
| 85 | MP0002067_abnormal_sensory_capabilities | 0.81882103 |
| 86 | MP0002733_abnormal_thermal_nociception | 0.81177095 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 0.81147087 |
| 88 | MP0001984_abnormal_olfaction | 0.78910306 |
| 89 | MP0010329_abnormal_lipoprotein_level | 0.78888335 |
| 90 | MP0001764_abnormal_homeostasis | 0.78425472 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.75819375 |
| 92 | MP0000516_abnormal_urinary_system | 0.75623321 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.75623321 |
| 94 | MP0003879_abnormal_hair_cell | 0.75525891 |
| 95 | MP0003631_nervous_system_phenotype | 0.75263236 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.75217222 |
| 97 | MP0005365_abnormal_bile_salt | 0.73108546 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.72434416 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.70853947 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.69831155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 5.22458675 |
| 2 | Hyperventilation (HP:0002883) | 4.77526085 |
| 3 | Pancreatic cysts (HP:0001737) | 4.21066033 |
| 4 | Gaze-evoked nystagmus (HP:0000640) | 4.18368717 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 3.89912923 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83019937 |
| 7 | Attenuation of retinal blood vessels (HP:0007843) | 3.66303171 |
| 8 | Pancreatic fibrosis (HP:0100732) | 3.66131683 |
| 9 | Congenital stationary night blindness (HP:0007642) | 3.57499976 |
| 10 | Clumsiness (HP:0002312) | 3.56990381 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.40707960 |
| 12 | True hermaphroditism (HP:0010459) | 3.26913949 |
| 13 | Fair hair (HP:0002286) | 3.25445141 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.10816073 |
| 15 | Abolished electroretinogram (ERG) (HP:0000550) | 3.07831338 |
| 16 | Protruding tongue (HP:0010808) | 3.06824701 |
| 17 | Nephronophthisis (HP:0000090) | 3.06762714 |
| 18 | Abnormality of the renal cortex (HP:0011035) | 3.05732246 |
| 19 | Chronic hepatic failure (HP:0100626) | 3.04910472 |
| 20 | Febrile seizures (HP:0002373) | 3.00949238 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 2.95403694 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89544163 |
| 23 | Cystic liver disease (HP:0006706) | 2.85031918 |
| 24 | Decreased circulating renin level (HP:0003351) | 2.78051135 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 2.76125021 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 2.76125021 |
| 27 | Facial diplegia (HP:0001349) | 2.73717436 |
| 28 | Absent speech (HP:0001344) | 2.68414408 |
| 29 | Stomach cancer (HP:0012126) | 2.62944399 |
| 30 | Generalized hypopigmentation of hair (HP:0011358) | 2.58831753 |
| 31 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.52533515 |
| 32 | Widely spaced teeth (HP:0000687) | 2.50011186 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.49427017 |
| 34 | Progressive inability to walk (HP:0002505) | 2.48055655 |
| 35 | Congenital hepatic fibrosis (HP:0002612) | 2.42072937 |
| 36 | Medial flaring of the eyebrow (HP:0010747) | 2.40857986 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.40633382 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.37557161 |
| 39 | Polydipsia (HP:0001959) | 2.37557161 |
| 40 | Central scotoma (HP:0000603) | 2.30848610 |
| 41 | Dysmetric saccades (HP:0000641) | 2.26351120 |
| 42 | Constricted visual fields (HP:0001133) | 2.26318319 |
| 43 | Inability to walk (HP:0002540) | 2.23695508 |
| 44 | Tubular atrophy (HP:0000092) | 2.19640923 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.19186608 |
| 46 | Hyperalaninemia (HP:0003348) | 2.19186608 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.19186608 |
| 48 | Dialeptic seizures (HP:0011146) | 2.15032736 |
| 49 | Hypothermia (HP:0002045) | 2.12612435 |
| 50 | Furrowed tongue (HP:0000221) | 2.10395222 |
| 51 | Decreased central vision (HP:0007663) | 2.07807806 |
| 52 | Keratoconus (HP:0000563) | 2.06936384 |
| 53 | Increased corneal curvature (HP:0100692) | 2.06936384 |
| 54 | Broad-based gait (HP:0002136) | 2.06601461 |
| 55 | Tubulointerstitial nephritis (HP:0001970) | 2.04735475 |
| 56 | Thyroiditis (HP:0100646) | 2.03057035 |
| 57 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97976142 |
| 58 | Macular degeneration (HP:0000608) | 1.97303931 |
| 59 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95937426 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95937426 |
| 61 | Hematochezia (HP:0002573) | 1.93103635 |
| 62 | Prostate neoplasm (HP:0100787) | 1.93054076 |
| 63 | Focal seizures (HP:0007359) | 1.91414447 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90845226 |
| 65 | Renal cortical cysts (HP:0000803) | 1.90511994 |
| 66 | Abnormal biliary tract physiology (HP:0012439) | 1.90361268 |
| 67 | Bile duct proliferation (HP:0001408) | 1.90361268 |
| 68 | Tubulointerstitial abnormality (HP:0001969) | 1.88806619 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87650701 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 1.87357446 |
| 71 | Portal hypertension (HP:0001409) | 1.84179111 |
| 72 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83908196 |
| 73 | Ketoacidosis (HP:0001993) | 1.81413533 |
| 74 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.79265573 |
| 75 | Scotoma (HP:0000575) | 1.79004850 |
| 76 | Congenital primary aphakia (HP:0007707) | 1.78733295 |
| 77 | Absence seizures (HP:0002121) | 1.78619422 |
| 78 | Hyperkalemia (HP:0002153) | 1.78404851 |
| 79 | Ileus (HP:0002595) | 1.77291915 |
| 80 | Gait imbalance (HP:0002141) | 1.76835684 |
| 81 | Large for gestational age (HP:0001520) | 1.76367067 |
| 82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76301387 |
| 83 | Abnormality of binocular vision (HP:0011514) | 1.76231842 |
| 84 | Diplopia (HP:0000651) | 1.76231842 |
| 85 | Abnormal ciliary motility (HP:0012262) | 1.75274987 |
| 86 | Progressive visual loss (HP:0000529) | 1.74833096 |
| 87 | Impaired smooth pursuit (HP:0007772) | 1.71567695 |
| 88 | Abnormality of T cell number (HP:0011839) | 1.70875462 |
| 89 | Hemiparesis (HP:0001269) | 1.70560676 |
| 90 | Polyuria (HP:0000103) | 1.68926589 |
| 91 | Ketosis (HP:0001946) | 1.64918558 |
| 92 | Spontaneous hematomas (HP:0007420) | 1.64906046 |
| 93 | Albinism (HP:0001022) | 1.64678934 |
| 94 | Abnormality of the hepatic vasculature (HP:0006707) | 1.63894243 |
| 95 | Atonic seizures (HP:0010819) | 1.63640752 |
| 96 | Postural instability (HP:0002172) | 1.62500157 |
| 97 | Abnormality of the prostate (HP:0008775) | 1.62142830 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 1.62120170 |
| 99 | Absent/shortened dynein arms (HP:0200106) | 1.62108140 |
| 100 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.62108140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.35384193 |
| 2 | ACVR1B | 3.51053490 |
| 3 | TAOK3 | 2.71937575 |
| 4 | BMPR1B | 2.44493862 |
| 5 | MAP4K2 | 2.20442122 |
| 6 | AKT3 | 2.19176226 |
| 7 | ADRBK2 | 2.12398979 |
| 8 | PIK3CG | 1.99094615 |
| 9 | BLK | 1.83543777 |
| 10 | INSRR | 1.71152241 |
| 11 | STK38L | 1.70067578 |
| 12 | GRK1 | 1.66787833 |
| 13 | NUAK1 | 1.62987415 |
| 14 | TXK | 1.59586547 |
| 15 | LATS1 | 1.52780948 |
| 16 | TRPM7 | 1.43031478 |
| 17 | MAPK13 | 1.39901527 |
| 18 | TEC | 1.38639263 |
| 19 | NTRK3 | 1.25733717 |
| 20 | OXSR1 | 1.24794895 |
| 21 | DAPK2 | 1.18954323 |
| 22 | WNK3 | 1.12389542 |
| 23 | PIK3CA | 1.11655051 |
| 24 | MKNK2 | 1.11250703 |
| 25 | MAP3K4 | 1.09212446 |
| 26 | KIT | 1.09074276 |
| 27 | ADRBK1 | 1.07631270 |
| 28 | SGK2 | 1.06355782 |
| 29 | NLK | 1.02227738 |
| 30 | EPHA3 | 1.01920064 |
| 31 | PINK1 | 0.99133162 |
| 32 | BRD4 | 0.98946727 |
| 33 | IRAK1 | 0.97766856 |
| 34 | PRKAA2 | 0.93534091 |
| 35 | PTK2B | 0.89564240 |
| 36 | TNK2 | 0.88101008 |
| 37 | ITK | 0.85775409 |
| 38 | JAK1 | 0.85622267 |
| 39 | ZAK | 0.83620735 |
| 40 | STK39 | 0.83051526 |
| 41 | OBSCN | 0.80873542 |
| 42 | MAP3K7 | 0.80767119 |
| 43 | STK3 | 0.79138762 |
| 44 | IKBKB | 0.78873331 |
| 45 | CASK | 0.77254984 |
| 46 | SYK | 0.76614109 |
| 47 | BMPR2 | 0.73526999 |
| 48 | CAMK1D | 0.69527552 |
| 49 | MAPKAPK3 | 0.68969891 |
| 50 | MELK | 0.68143223 |
| 51 | CAMK1G | 0.67645881 |
| 52 | FER | 0.67378100 |
| 53 | PRKCE | 0.67184178 |
| 54 | BTK | 0.66334148 |
| 55 | TGFBR1 | 0.65656616 |
| 56 | STK38 | 0.64497911 |
| 57 | CAMKK2 | 0.59202460 |
| 58 | TNIK | 0.55324825 |
| 59 | JAK3 | 0.53818101 |
| 60 | MAPKAPK5 | 0.53125645 |
| 61 | RIPK4 | 0.52497887 |
| 62 | CHUK | 0.52436135 |
| 63 | LYN | 0.51999423 |
| 64 | GRK7 | 0.51454819 |
| 65 | SGK494 | 0.50898390 |
| 66 | SGK223 | 0.50898390 |
| 67 | CDK12 | 0.50175955 |
| 68 | PAK3 | 0.49882294 |
| 69 | MAPK11 | 0.49590760 |
| 70 | JAK2 | 0.48360384 |
| 71 | EIF2AK3 | 0.48015568 |
| 72 | FGFR3 | 0.47904652 |
| 73 | PDK2 | 0.47858789 |
| 74 | MAP3K14 | 0.47733316 |
| 75 | PRKCQ | 0.47275902 |
| 76 | FGFR2 | 0.47053026 |
| 77 | LCK | 0.46655202 |
| 78 | TYK2 | 0.45864202 |
| 79 | FES | 0.44674392 |
| 80 | IKBKE | 0.43838558 |
| 81 | HCK | 0.43804190 |
| 82 | MUSK | 0.43135407 |
| 83 | BRSK2 | 0.43096194 |
| 84 | WNK1 | 0.42864174 |
| 85 | PRKAA1 | 0.42753504 |
| 86 | NEK6 | 0.41573791 |
| 87 | SGK1 | 0.40927949 |
| 88 | PRKACB | 0.38268471 |
| 89 | ERBB2 | 0.38256426 |
| 90 | ABL1 | 0.38124341 |
| 91 | PDK1 | 0.37947168 |
| 92 | SGK3 | 0.35434860 |
| 93 | PKN1 | 0.35082884 |
| 94 | MARK3 | 0.34679443 |
| 95 | CAMK4 | 0.34434307 |
| 96 | CAMK1 | 0.33805037 |
| 97 | IGF1R | 0.33191682 |
| 98 | WNK4 | 0.32708197 |
| 99 | DYRK1A | 0.32553885 |
| 100 | MAP2K6 | 0.32078082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 2.51175921 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29829767 |
| 3 | ABC transporters_Homo sapiens_hsa02010 | 2.17758722 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14148516 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.13141276 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12229891 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.07753982 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.07354498 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05865664 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93539430 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.92058924 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.84840301 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73702832 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71768754 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.66745267 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63285751 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57412470 |
| 18 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.53292603 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48371965 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46608841 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.45895393 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.43330571 |
| 23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40585980 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37818606 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35987818 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34662945 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.26510359 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26143063 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.23478762 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23216556 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12831454 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09898491 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08864415 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.08232115 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07876224 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05423215 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05163688 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04479124 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00900411 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00225221 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.00008228 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99239315 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98557079 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98035851 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.97988779 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96994575 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.95609007 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92330165 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.90597019 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90179324 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89032640 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88764257 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88742092 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88337585 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87490583 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86386988 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 0.86079317 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85952699 |
| 59 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83775113 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83191739 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78664113 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77990600 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77910473 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.77445534 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77382213 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74444336 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.73678946 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72715396 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.70199887 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69028371 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.68923383 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68309916 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68211168 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67423338 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66083322 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65654819 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64831186 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63820061 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62733876 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58905894 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58826661 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58192792 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57369124 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54936028 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53863205 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53833790 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52396013 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51769755 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50839232 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50350391 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.48671654 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48148925 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.48093746 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46541767 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46280155 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46155703 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43729049 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.41785509 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38050576 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.37286577 |

